European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS

VessConnect “Plug Flow” innovative technology providing patients a safer, more effective and less costly procedure for vascular anastomosis

Obiettivo

Proposal title*
VessConnect “Plug & Flow” innovative technology providing every year to 270.000 European patients a safer, more effective and less costly procedure for vascular anastomosis

ACRONYM:

PLUGandFLOW

Free keywords
vascular anastomosis, microvascular anastomosis, microsurgery, NiTiNol, advanced materials, bio-absorbable Shape Memory Polymers, Advanced Material Innovation applied to surgical device, microsurgery

Abstract:
Vascular anastomosis, the surgical union of two blood vessels, has been technically performed in the same way for the last 100 years: suturing both ends of the vessels with microsutures. Even though several devices have appeared to ease the proceeding, none of them could improve traditional techniques. The result is a time-consuming procedure, with a long learning curve, which is not widely spread in private health systems because of its dangers and lack of efficiency and reliability.
Surg Solution’s, is a start-up company founded by two surgeons, one bio-medical engineer and a business consultant, that has designed, prototyped and solicited a PCT patent for a device, VessConnect, that will reduce costs and probabilities of failure in anastomosis procedures. The product, a stent-like device, relies on the shape-memory characteristics of NiTiNol.
Vascular anastomosis is a widely spread surgical procedure used in organ transplants and general reconstruction surgery, among others. Vessconnect has the potential to impact on the health improvement of the 270.000 European patients that we estimate need a surgery involving an anastomosis every year. Surg Solution aims to gain with VessConnect, 45% market-share of microvascular anastomosis in top European Markets in 5 years, generating €18M on revenues by 2021 with a 77% EBITDA margin.
VessConnect is at TRL6. We aim to launch the product by mid 2019, bringing to patients a safer surgery, to surgeons an easier procedure and to the healthcare system a more efficient solution to perform vascu

Invito a presentare proposte

H2020-SMEInst-2016-2017

Vedi altri progetti per questo bando

Bando secondario

H2020-SMEINST-1-2016-2017

Meccanismo di finanziamento

SME-1 - SME instrument phase 1

Coordinatore

SURG SOLUTIONS SL
Contribution nette de l'UE
€ 50 000,00
Indirizzo
AVENIDA MADRID 139 PLANTA 7 PUERTA 2
08028 BARCELONA
Spagna

Mostra sulla mappa

PMI

L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione.

Regione
Este Cataluña Barcelona
Tipo di attività
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Collegamenti
Costo totale
€ 71 429,00